Nocarnickelamides B (Compound 2) is a linear peptide and an inhibitor of ROCK1/2. It exhibits dual inhibitory activity against ROCK1 and ROCK2, with IC50 values of 14.9 µM and 21.9 µM, respectively. This compound binds to the ATP binding site and inhibits ROCK-mediated cytoskeletal contraction markers, such as myosin light chain activation. Nocarnickelamides B can be utilized in glaucoma research.
Molecular Weight:
148.249
Formula:
C11H16
Target:
Myosin|||ROCK
* VAT and and shipping costs not included. Errors and price changes excepted
